Loading...
Please wait, while we are loading the content...
Similar Documents
Lobeglitazone Exerts Anti-Inflammatory Effect in Lipopolysaccharide-Induced Bone-Marrow Derived Macrophages
| Content Provider | MDPI |
|---|---|
| Author | Jeong, Dabin Ko, Wan-Kyu Kim, Seong-Jun Han, Gong-Ho Lee, Daye Sheen, Seung-Hun Sohn, Seil |
| Copyright Year | 2021 |
| Description | The purpose of this study is to elucidate the anti-inflammatory effect of lobeglitazone (LOBE) in lipopolysaccharide (LPS)-induced bone-marrow derived macrophages (BMDMs). We induced nitric oxide (NO) production and pro-inflammatory gene expression through LPS treatment in BMDMs. The changes of NO release and expression of pro-inflammatory mediators by LOBE were assessed via NO quantification assay and a real-time quantitative polymerase chain reaction (RT-qPCR), respectively. In addition, the regulatory effect of LOBE on activation of mitogen-activated protein kinase (MAPK) signaling pathway was investigated by measuring the phosphorylation state of extracellular regulatory protein (ERK) and c-Jun N-terminal kinase (JNK) proteins by Western blot. Our results show that LOBE significantly reduced LPS-induced NO production and pro-inflammatory gene expression of interleukin-1β (IL-1β), IL-6, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and monocyte chemoattractant protein-1 (MCP-1). Moreover, LOBE reduced phosphorylation levels of ERK and JNK of MAPK signaling pathway. In conclusion, LOBE exerts an anti-inflammatory effect in LPS-induced BMDMs by suppression of NO production and pro-inflammatory gene expression, and this effect is potentially through inhibition of the MARK signaling pathway. |
| Starting Page | 1432 |
| e-ISSN | 22279059 |
| DOI | 10.3390/biomedicines9101432 |
| Journal | Biomedicines |
| Issue Number | 10 |
| Volume Number | 9 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2021-10-10 |
| Access Restriction | Open |
| Subject Keyword | Biomedicines Dentistry and Oral Surgery Bone-marrow Derived Macrophages Lipopolysaccharide Lobeglitazone Anti-inflammation Mitogen-activated Protein Kinase |
| Content Type | Text |
| Resource Type | Article |